 Maryann Degroote
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antitubercular Agents | 7 | 2014 | 169 | 0.810 |
Why?
| | Capreomycin | 1 | 2011 | 2 | 0.390 |
Why?
| | Mycobacterium | 3 | 2018 | 103 | 0.290 |
Why?
| | Models, Biological | 1 | 2011 | 1621 | 0.240 |
Why?
| | Tuberculosis | 3 | 2012 | 241 | 0.220 |
Why?
| | Mycobacterium tuberculosis | 5 | 2014 | 268 | 0.210 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2014 | 112 | 0.200 |
Why?
| | Mycobacterium Infections | 3 | 2017 | 61 | 0.190 |
Why?
| | Benzothiazoles | 1 | 2018 | 32 | 0.150 |
Why?
| | Drug Discovery | 1 | 2018 | 123 | 0.140 |
Why?
| | Anti-Bacterial Agents | 3 | 2018 | 1481 | 0.140 |
Why?
| | Respiratory System | 1 | 2017 | 137 | 0.130 |
Why?
| | Phylogeny | 2 | 2017 | 789 | 0.120 |
Why?
| | Isoniazid | 2 | 2012 | 52 | 0.120 |
Why?
| | Tuberculosis, Multidrug-Resistant | 2 | 2012 | 46 | 0.120 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2012 | 161 | 0.120 |
Why?
| | Mice | 8 | 2018 | 14871 | 0.110 |
Why?
| | Monte Carlo Method | 1 | 2011 | 138 | 0.090 |
Why?
| | Tissue Distribution | 1 | 2011 | 286 | 0.090 |
Why?
| | Torticollis | 1 | 2011 | 12 | 0.090 |
Why?
| | Azithromycin | 1 | 2011 | 80 | 0.090 |
Why?
| | Biological Transport | 1 | 2011 | 374 | 0.090 |
Why?
| | Bayes Theorem | 1 | 2011 | 329 | 0.090 |
Why?
| | Macrolides | 2 | 2011 | 56 | 0.080 |
Why?
| | Cystic Fibrosis | 2 | 2011 | 955 | 0.080 |
Why?
| | Metabolomics | 1 | 2014 | 521 | 0.080 |
Why?
| | Autophagy | 1 | 2011 | 235 | 0.080 |
Why?
| | Otitis Media | 1 | 2011 | 142 | 0.080 |
Why?
| | Computer Simulation | 1 | 2011 | 873 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2012 | 3535 | 0.070 |
Why?
| | Bacterial Proteins | 1 | 2012 | 736 | 0.070 |
Why?
| | Animals | 9 | 2018 | 31708 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2011 | 4694 | 0.060 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 62 | 0.060 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2005 | 63 | 0.060 |
Why?
| | Kidney | 1 | 2011 | 1188 | 0.060 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 63 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3408 | 0.060 |
Why?
| | Lung | 2 | 2012 | 3561 | 0.050 |
Why?
| | Drug Design | 2 | 2012 | 148 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2012 | 1144 | 0.040 |
Why?
| | Amides | 1 | 2018 | 86 | 0.040 |
Why?
| | Mycolic Acids | 1 | 2017 | 6 | 0.040 |
Why?
| | Salmonella typhimurium | 1 | 1999 | 164 | 0.040 |
Why?
| | Base Composition | 1 | 2017 | 75 | 0.040 |
Why?
| | Oregon | 1 | 2017 | 66 | 0.040 |
Why?
| | Bacterial Typing Techniques | 1 | 2017 | 40 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 1999 | 306 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2018 | 300 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 502 | 0.040 |
Why?
| | Species Specificity | 1 | 2018 | 542 | 0.040 |
Why?
| | Genes, Bacterial | 1 | 2017 | 157 | 0.030 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 1999 | 285 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2005 | 2286 | 0.030 |
Why?
| | Female | 6 | 2014 | 59520 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 311 | 0.030 |
Why?
| | Humans | 9 | 2017 | 114699 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 485 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 723 | 0.030 |
Why?
| | Phagosomes | 1 | 2011 | 38 | 0.020 |
Why?
| | HIV Infections | 1 | 2005 | 2469 | 0.020 |
Why?
| | Pyrazinamide | 1 | 2011 | 6 | 0.020 |
Why?
| | Aza Compounds | 1 | 2011 | 11 | 0.020 |
Why?
| | COS Cells | 1 | 2011 | 175 | 0.020 |
Why?
| | Fluoroquinolones | 1 | 2011 | 41 | 0.020 |
Why?
| | Autopsy | 1 | 2011 | 84 | 0.020 |
Why?
| | Lysosomes | 1 | 2011 | 123 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 198 | 0.020 |
Why?
| | Rifampin | 1 | 2011 | 68 | 0.020 |
Why?
| | Ear, Middle | 1 | 2011 | 89 | 0.020 |
Why?
| | Drug Resistance, Bacterial | 1 | 2011 | 155 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 641 | 0.020 |
Why?
| | Microtubule-Associated Proteins | 1 | 2011 | 174 | 0.020 |
Why?
| | Sirolimus | 1 | 2011 | 181 | 0.020 |
Why?
| | Quinolines | 1 | 2011 | 129 | 0.020 |
Why?
| | HeLa Cells | 1 | 2011 | 562 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 616 | 0.020 |
Why?
| | Adult | 4 | 2014 | 30553 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 750 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 951 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2008 | 136 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2014 | 9088 | 0.020 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2005 | 70 | 0.020 |
Why?
| | Age Distribution | 1 | 2005 | 342 | 0.010 |
Why?
| | Sex Distribution | 1 | 2005 | 337 | 0.010 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 92 | 0.010 |
Why?
| | Macrophages | 1 | 2011 | 1263 | 0.010 |
Why?
| | Reference Values | 1 | 2005 | 743 | 0.010 |
Why?
| | Prospective Studies | 1 | 2014 | 6220 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2005 | 1796 | 0.010 |
Why?
| | Genotype | 1 | 2005 | 1760 | 0.010 |
Why?
| | Rats | 1 | 2008 | 4958 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2313 | 0.010 |
Why?
| | Male | 3 | 2014 | 55606 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2005 | 12555 | 0.010 |
Why?
| | Disease Progression | 1 | 2005 | 2380 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2005 | 3003 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 323 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 283 | 0.010 |
Why?
| | Virulence | 1 | 1999 | 227 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2540 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 270 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2005 | 4411 | 0.010 |
Why?
| | Risk Assessment | 1 | 2005 | 2968 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 4895 | 0.010 |
Why?
| | Middle Aged | 2 | 2005 | 26738 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 1982 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 6347 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1999 | 2785 | 0.010 |
Why?
| | Mutation | 1 | 1999 | 3346 | 0.000 |
Why?
| | Aged | 1 | 2005 | 19074 | 0.000 |
Why?
|
|
Degroote's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|